OTULIN/CYLD can interact with LUBAC (linear ubiquitin chain assembly complex) through the PUB (PNGase/UBA or UBX) domain of HOIP (a catalytic subunit of LUBAC), thereby inhibiting the NF-κB pathway and exerting anti-tumor effects [51]. This evidence concerns the gene CYLD and neoplasm.